Le Lézard
Classified in: Science and technology, Business
Subject: PDT

New Novel, Giants of Iniquity, Entertains and Raises Societal Issues; San Francisco Foreshadows USA's Future

SAN FRANCISCO, Oct. 22, 2019 /PRNewswire/ -- A new novel, Giants of Iniquity: a San Francisco Omen, entertains with a tongue-in-cheek tone while exploring societal issues exemplified in San Francisco and relevant in the broader USA. The humorous depiction of alien giants invading San Francisco acts as a metaphor for the big tech firms, political power agents, corrupt spiritual leaders, and corporate monopolies.

Giants of Iniquity: a San Francisco Omen (PRNewsfoto/Giants of Iniquity)

The novel is about a prophet who lives in San Francisco between Nob Hill and the Tenderloin and senses an invasive shadowy paranormal force. His observations about San Francisco act as a social commentary, and the novel functions as a modern allegory, full of fun and humor. Dichotomies depicted include abject poverty contrasted with extreme wealth, political extremism versus a humble quest for freedom, powerlessness versus the extremely powerful, totalitarianism versus independence, and monopoly and corruption versus entrepreneurship.

Giants of Iniquity is a cautionary tale about what America is becoming. It pokes fun at the social, political, religious, corporate, and government institutions. The novel makes readers ask, "Are we repeating the lessons we should have learned from history?" "Are we self-deceived?" "Where are we spiritually?" "Where is our culture headed?"

Giants of Iniquity brings the excitement and intrigue of paranormal discovery together with a supernatural battle between spiritual forces in an age of advanced technology and cultural shifting.

Due for release in eBook and paperback on November 4, the eBook can now be pre-ordered for only $.99 cents on Amazon:



Interviews can be scheduled directly with the author:

Jason Covington



SOURCE Giants of Iniquity

These press releases may also interest you

at 08:30
Chimeron Bio, an RNA therapeutics company, and George Mason University's National Center for Biodefense and Infectious Diseases (NCBID), a leading institute conducting pioneering research on infectious diseases including diagnostic, therapeutics and...

at 08:30
Calix, Inc. today announced a new partner program that enhances its ability to equip communications service providers (CSPs) with the expertise and solutions to meet and exceed subscriber demands. The new program enables the Calix team to...

at 08:22
Tribit Audio Limited (Tribit), the innovative wireless audio brand responsible for hit products like the StormBox, MaxSound Plus and XSound Go, is introducing two new audio products: the StormBox Micro Bluetooth speaker and the FlyBuds 1 earbuds. The...

at 08:22
Kodiak Sciences Inc. , a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, announced today that management will present at the following upcoming virtual investor...

at 08:20
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a proprietary technology to produce fully human polyclonal antibodies without the need for human plasma donors, today announced in vitro data demonstrating that SAB-185, its...

at 08:20
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, announced today that warrants to purchase approximately 5.4 million shares of...

News published on 22 october 2019 at 09:07 and distributed by: